FDA Import Refusal 1FX-0444941-0/10002/2 — INTAS PHARMACEUTICALS LTD
The FDA refused shipment 1FX-0444941-0/10002/2 from INTAS PHARMACEUTICALS LTD (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75